Skip to main content
Erschienen in: Pediatric Radiology 6/2018

06.04.2018 | Original Article

Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?

verfasst von: Dennis Dünger, Matthias Krause, Daniel Gräfe, Andreas Merkenschlager, Christian Roth, Ina Sorge

Erschienen in: Pediatric Radiology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Brain imaging is the most common examination in pediatric magnetic resonance imaging (MRI), often combined with the use of a gadolinium-based contrast medium. The application of gadolinium-based contrast medium poses some risk. There is limited evidence of the benefits of contrast medium in pediatric brain imaging.

Objective

To assess the diagnostic gain of contrast-enhanced sequences in brain MRI when the unenhanced sequences are normal.

Materials and methods

We retrospectively assessed 6,683 brain MR examinations using contrast medium in children younger than 16 years in the pediatric radiology department of the University Hospital Leipzig to determine whether contrast-enhanced sequences delivered additional, clinically relevant information to pre-contrast sequences. All examinations were executed using a 1.5-T or a 3-T system.

Results

In 8 of 3,003 (95% confidence interval 0.12–0.52%) unenhanced normal brain examinations, a relevant additional finding was detected when contrast medium was administered. Contrast enhancement led to a change in diagnosis in only one of these cases.

Conclusion

Children with a normal pre-contrast brain MRI rarely benefit from contrast medium application. Comparing these results to the risks and disadvantages of a routine gadolinium application, there is substantiated numerical evidence for avoiding routine administration of gadolinium in a pre-contrast normal MRI examination.
Literatur
1.
Zurück zum Zitat Kanal E (2016) Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience. Magn Reson Imaging 34:1341–1345CrossRefPubMed Kanal E (2016) Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience. Magn Reson Imaging 34:1341–1345CrossRefPubMed
2.
Zurück zum Zitat Collidge TA, Thomson PC, Mark PB et al (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245:168–175CrossRefPubMed Collidge TA, Thomson PC, Mark PB et al (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245:168–175CrossRefPubMed
4.
Zurück zum Zitat Todd DJ, Kagan A, Chibnik LB et al (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441CrossRefPubMed Todd DJ, Kagan A, Chibnik LB et al (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441CrossRefPubMed
5.
Zurück zum Zitat Grobner T (2006) Gadolinium -- a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108CrossRefPubMed Grobner T (2006) Gadolinium -- a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108CrossRefPubMed
6.
Zurück zum Zitat Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362CrossRefPubMed Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362CrossRefPubMed
7.
Zurück zum Zitat Quattrocchi CC, Mallio CA, Errante Y et al (2015) Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Investig Radiol 50:470–472CrossRef Quattrocchi CC, Mallio CA, Errante Y et al (2015) Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Investig Radiol 50:470–472CrossRef
8.
Zurück zum Zitat Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783–791CrossRefPubMed Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783–791CrossRefPubMed
9.
Zurück zum Zitat Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809CrossRefPubMed Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809CrossRefPubMed
10.
Zurück zum Zitat Murata N, Gonzalez-Cuyar LF, Murata K et al (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Investig Radiol 51:447–453CrossRef Murata N, Gonzalez-Cuyar LF, Murata K et al (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Investig Radiol 51:447–453CrossRef
11.
Zurück zum Zitat White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Investig Radiol 41:272–278CrossRef White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Investig Radiol 41:272–278CrossRef
12.
Zurück zum Zitat Weberling LD, Kieslich PJ, Kickingereder P et al (2015) Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration. Investig Radiol 50:743–748CrossRef Weberling LD, Kieslich PJ, Kickingereder P et al (2015) Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration. Investig Radiol 50:743–748CrossRef
13.
Zurück zum Zitat Zhang Y, Cao Y, Shih GL et al (2017) Extent of signal hyperintensity on unenhanced T1-weighted brain MR images after more than 35 administrations of linear gadolinium-based contrast agents. Radiology 282:516–525CrossRefPubMed Zhang Y, Cao Y, Shih GL et al (2017) Extent of signal hyperintensity on unenhanced T1-weighted brain MR images after more than 35 administrations of linear gadolinium-based contrast agents. Radiology 282:516–525CrossRefPubMed
14.
Zurück zum Zitat Miller JH, Hu HH, Pokorney A et al (2015) MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations. Pediatrics 136:e1637–e1640 Miller JH, Hu HH, Pokorney A et al (2015) MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations. Pediatrics 136:e1637–e1640
15.
Zurück zum Zitat Roberts DR, Holden KR (2016) Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast. Brain Dev 38:331–336 Roberts DR, Holden KR (2016) Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast. Brain Dev 38:331–336
16.
Zurück zum Zitat McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMed McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMed
17.
Zurück zum Zitat Flood TF, Stence NV, Maloney JA et al (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222–228CrossRefPubMed Flood TF, Stence NV, Maloney JA et al (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222–228CrossRefPubMed
18.
Zurück zum Zitat Roberts DR, Chatterjee AR, Yazdani M et al (2016) Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent. AJNR Am J Neuroradiol 37:2340–2347CrossRefPubMedPubMedCentral Roberts DR, Chatterjee AR, Yazdani M et al (2016) Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent. AJNR Am J Neuroradiol 37:2340–2347CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Hu HH, Pokorney A, Towbin RB, Miller JH (2016) Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr Radiol 46:1590–1598 Hu HH, Pokorney A, Towbin RB, Miller JH (2016) Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr Radiol 46:1590–1598
20.
Zurück zum Zitat Elster AD, Rieser GD (1989) Gd-DTPA-enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use. AJR Am J Roentgenol 153:1265–1268CrossRefPubMed Elster AD, Rieser GD (1989) Gd-DTPA-enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use. AJR Am J Roentgenol 153:1265–1268CrossRefPubMed
21.
Zurück zum Zitat Baierl P, Muhlsteffen A, Haustein J et al (1990) Comparison of plain and Gd-DTPA-enhanced MR-imaging in children. Pediatr Radiol 20:515–519CrossRefPubMed Baierl P, Muhlsteffen A, Haustein J et al (1990) Comparison of plain and Gd-DTPA-enhanced MR-imaging in children. Pediatr Radiol 20:515–519CrossRefPubMed
22.
Zurück zum Zitat Eldevik OP, Brunberg JA (1994) Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age. AJNR Am J Neuroradiol 15:1001–1008PubMed Eldevik OP, Brunberg JA (1994) Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age. AJNR Am J Neuroradiol 15:1001–1008PubMed
23.
Zurück zum Zitat Petrou M, Foerster B, Maly PV et al (2007) Added utility of gadolinium in the magnetic resonance imaging (MRI) workup of seizures in children younger than 2 years. J Child Neurol 22:200–203CrossRefPubMed Petrou M, Foerster B, Maly PV et al (2007) Added utility of gadolinium in the magnetic resonance imaging (MRI) workup of seizures in children younger than 2 years. J Child Neurol 22:200–203CrossRefPubMed
24.
Zurück zum Zitat Foerster BR, Ksar J, Petrou M et al (2006) Value of gadolinium in brain MRI examinations for developmental delay. Pediatr Neurol 35:126–130CrossRefPubMed Foerster BR, Ksar J, Petrou M et al (2006) Value of gadolinium in brain MRI examinations for developmental delay. Pediatr Neurol 35:126–130CrossRefPubMed
25.
Zurück zum Zitat Gutierrez JE, Rosenberg M, Seemann J et al (2015) Safety and efficacy of gadobutrol for contrast-enhanced magnetic resonance imaging of the central nervous system: results from a multicenter, double-blind, randomized, comparator study. Magn Reson Insights 8:1–10PubMedPubMedCentral Gutierrez JE, Rosenberg M, Seemann J et al (2015) Safety and efficacy of gadobutrol for contrast-enhanced magnetic resonance imaging of the central nervous system: results from a multicenter, double-blind, randomized, comparator study. Magn Reson Insights 8:1–10PubMedPubMedCentral
Metadaten
Titel
Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?
verfasst von
Dennis Dünger
Matthias Krause
Daniel Gräfe
Andreas Merkenschlager
Christian Roth
Ina Sorge
Publikationsdatum
06.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 6/2018
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-017-3999-2

Weitere Artikel der Ausgabe 6/2018

Pediatric Radiology 6/2018 Zur Ausgabe

Hermes

Hermes

Minisymposium: Juvenile Idiopathic Arthritis

Update on imaging in juvenile idiopathic arthritis

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.